How Common Is Diabetic Retinopathy?

Headquartered in Tucson, Arizona, Retina Associates provides eye care services, treating conditions affecting the retina and vitreous at the back of the eye. Under the leadership of Dr. Cameron Javid, one of the conditions that Retina Associates treats is diabetic retinopathy.

People with diabetes are at risk of developing diabetic retinopathy. This occurs when high blood sugar levels affect blood vessels in the retina, the light-sensitive tissue at the back of the eye. The blood vessels may swell and leak or close, stopping blood flow. Both of these events can rob a person of his or her vision.

Diabetic retinopathy is actually the number one cause of blindness among America’s working age population. At some point, one in every three people with diabetes will develop retinopathy. The Centers for Disease Control estimates that from 2010 to 2050, the number of Americans with the condition will almost double from 7.7 million to reach 14.6 million.

Diabetic retinopathy poses a particular risk to people’s vision, especially because it has no symptoms in its early stages. The symptoms that a person may notice when the disease progresses include blurry vision, spotty vision, loss of color vision, or loss of central vision. It is important for people with type 1 or type 2 diabetes to take extra precautions to reduce their risk of developing the condition. These precautions may include monitoring blood sugar levels according to the doctor’s instructions, quitting smoking, eating healthy foods, exercising often, and scheduling a comprehensive dilated eye exam every year.

ELOVL2 Gene Expression Linked with Age-Related Eye Diseases

Located in Tucson, Arizona, Retina Associates serves the needs of patients requiring a wide range of eye care services. Led by Dr. Cameron Javid, the experienced Retina Associates team has an extensive understanding of the latest trends in medical technology and research regarding vision and eye health.

One recent University of California, San Diego mice model study brought focus to the Elongation of very long chain fatty acids protein 2 gene (ELOVL2) gene and its role in the eye’s aging process. The ELOVL2 gene has a critical role in producing long-chain omega-6 and omega-3 polyunsaturated fatty acids, which are essential to inflammation response and energy production, as well as ensuring cell membrane integrity.

The new study shows that ELOVL2 gene expression also regulates aging in the retina, and finds a molecular-level linkage between fatty acids that it regulates, such as DHA, and visual functions. DHA is known for its beneficial effects in the eye, including protection from oxidative, or bright-light, stress, and when present in the photoreceptors promotion of a healthy retina. It is also linked to improvements in conditions such as dry eyes, diabetic eye disease, and age-related macular (AMD) degeneration.

The research suggests that ELOVL2 is related to a number of conditions that emerge as people grow older, and that encouraging its expression may be a key to tackling age-related eye diseases.

The Symptoms and Effects of Macula Degeneration

Introducing the American College of Surgeons GVS Program

Located in Tucson, Arizona, Retina Associates provides advanced care for diseases impacting the retina, macula, and vitreous. The office is staffed by physicians certified by the American Board of Ophthalmology, including Cameron Javid MD FACS, Retina Associates engages with a number of organizations, including the American College of Surgeons.

The American College of Surgeons (ACS) has recently introduced the ACS Geriatric Surgery Verification (GSV) Program. Through this quality-improvement initiative, 30 unique surgical standards have been developed, with a mission of comprehensively elevating surgical practices and prognoses for the nation’s expanding senior population. Hospitals that adopt the ACS GSV Program will enjoy a streamlined groundwork for optimized support and outcomes for older patients.

The ACS Coalition for Quality in Geriatric Surgery Project established the program in partnership with the John A. Hartford Foundation, representing the collective input of numerous regulatory groups, health care leaders, patients, advocacy organizations, and more. Standards developed through the program touch on various areas of medical care, from tips for improved patient communications to revised screening schedules for geriatric vulnerabilities. More information about the GSV Program can be found online at